Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microfluidic technologies in drug discovery.

Johan Pihl1, Mattias Karlsson, Daniel T Chiu

  • 1Cellectricon AB, Fabriksgatan 7, SE-412 50 Gothenburg, Sweden. johan.pihl@cellectricon.com

Drug Discovery Today
|October 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-channel-count neural recording and stimulation platform with 5,376 simultaneous recording channels.

bioRxiv : the preprint server for biology·2026
Same author

Measuring the Degree of Labeling of Antibody-Dye Conjugates with a Single-Molecule-Sensitive Digital Flow Cytometer.

Analytical chemistry·2026
Same author

Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025
Same author

Optimal medical therapy in patients with reduced left ejection fraction undergoing coronary artery bypass graft surgery.

BMC cardiovascular disorders·2025
Same author

Heterogeneity of Extracellular Vesicles and Non-Vesicular Nanoparticles in Glioblastoma.

Journal of extracellular vesicles·2025
Same author

ECG-based beat-to-beat assessment of AV node conduction properties during AF.

Frontiers in physiology·2025
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Microfluidic systems offer advantages like reduced sample use and faster experiments for drug discovery. These microscale technologies enable parallelization and cost reduction, providing unique insights not possible with larger systems.

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Chemical Engineering
  • Pharmaceutical Sciences

Background:

  • Microfluidic systems are gaining traction in drug discovery.
  • Traditional drug discovery methods face challenges in efficiency and cost.
  • Microscale fluid dynamics offer unique analytical capabilities.

Purpose of the Study:

  • To review the implementation of microfluidic systems in drug discovery.
  • To highlight the advantages of microfluidic technologies in pharmaceutical research.
  • To discuss the potential of microfluidics for accelerating drug development.

Main Methods:

  • Review of current literature on microfluidic applications in drug discovery.
  • Analysis of advantages including sample volume, speed, and parallelization.

Related Experiment Videos

  • Exploration of unique fluid behaviors in microscale environments.

    • Main Results:

    • Microfluidics enables significant reduction in sample consumption and experiment time.
    • Massive parallelization is achievable, lowering the cost per data point.
    • Unique fluid properties at the microscale allow for novel data acquisition.

    Conclusions:

    • Microfluidic systems are valuable tools across multiple stages of drug discovery.
    • The benefits of microfluidics include enhanced efficiency, reduced costs, and novel analytical insights.
    • Further integration of microfluidic technologies promises to accelerate pharmaceutical innovation.